CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 126 enrolled
Drug / intervention
smoking questionnairebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02192164
NCT02192164N/ACompleted
CompareCT.gov

Non-interventional Study Of The Effect Of Smoking Status Of The Patient On The Success Of Etanercept Therapy In Psoriasis

Pfizer·observational·Posted Jul 16, 2014·Updated Jun 28, 2017

In Brief

An observational study evaluating smoking questionnaire for Plaque Psoriasis. Completed, enrolled 126 participants across 8 sites.

Detailed Summary

Pilot observational study to describe the relationship between the smoking status of a psoriatic individual and the success of etanercept therapy in psoriasis treatment

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPlaque Psoriasis
CountriesHungary
Collaborators--

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedJul 16, 2014
Enrollment StartNov 1, 2013
Primary CompletionMay 1, 2016
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 12.0 years ago

Interventions

smoking questionnairebehavioral

patients fill in a smoking questionnaire about their smoking habits